William Osburn

Assistant Professor

20062018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Hepacivirus Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Neutralizing Antibodies Medicine & Life Sciences
NF-E2-Related Factor 2 Medicine & Life Sciences
Hepatitis C virus Agriculture & Biology
Infection Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2018

Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population

Rose, R., Lamers, S. L., Massaccesi, G., Osburn, W., Ray, S. C., Thomas, D. L., Cox, A. & Laeyendecker, O. B., Mar 1 2018, In : Infection, Genetics and Evolution. 58, p. 77-82 6 p.

Research output: Contribution to journalArticle

hepatitis
Hepatitis C virus
Hepacivirus
Cluster Analysis
virus

Rapid and sensitive detection of viral nucleic acids using silicon microchips

Powell, L., Wiederkehr, R. S., Damascus, P., Fauvart, M., Buja, F., Stakenborg, T., Ray, S. C., Fiorini, P. & Osburn, W., Jun 7 2018, In : Analyst. 143, 11, p. 2596-2603 8 p.

Research output: Contribution to journalArticle

Nucleic acids
nucleic acid
Silicon
Nucleic Acids
silicon

Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1

El-Diwany, R., Cohen, V. J., Mankowski, M. C., Wasilewski, L. N., Brady, J. K., Snider, A. E., Osburn, W., Murrell, B., Ray, S. C. & Bailey, J., Feb 1 2017, In : PLoS Pathogens. 13, 2, e1006235.

Research output: Contribution to journalArticle

Scavenger Receptors
Neutralizing Antibodies
Hepacivirus
Epitopes
Monoclonal Antibodies

Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection

Rodrigo, C., Walker, M. R., Leung, P., Eltahla, A. A., Grebely, J., Dore, G. J., Applegate, T., Page, K., Dwivedi, S., Bruneau, J., Morris, M. D., Cox, A., Osburn, W., Kim, A. Y., Schinkel, J., Shoukry, N. H., Lauer, G. M., Maher, L., Hellard, M., Prins, M. & 3 othersLuciani, F., Lloyd, A. R. & Bull, R. A., Apr 1 2017, In : Infection, Genetics and Evolution. 49, p. 88-96 9 p.

Research output: Contribution to journalArticle

hepatitis C
hepatitis
Hepatitis C
Neutralizing Antibodies
neutralizing antibodies

New therapies for treating hepatitis C virus: Impact on laboratory testing recommendations and clinical management

Tolan, N. V., Horowitz, G. L., Graham, C. S., Hillyard, D., Osburn, W. & Ray, S. C., Dec 1 2017, In : Clinical Chemistry. 63, 12, p. 1799-1805 7 p.

Research output: Contribution to journalComment/debate

Viruses
Hepacivirus
Testing
Therapeutics